Wesana Clinics Won't Be Ketamine Mills Says CEO

Wesana Health (OTC: WSNAF) is a life sciences company focused on the advancement of psychedelic medicines that will target traumatic brain injuries. The company’s CEO Daniel Carcillo is a former professional hockey player who can speak from the experience of having suffered numerous injuries. He believes the Wesana clinics will offer better treatment than the currently trendy “ketamine mills.” He says Wesana will focus on insurance reimbursement.

Video Staff


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 31 mins

Researchers Seek to Remove ‘Trip’ as Popularity of Psychedelic Treatments Grows

@GreenMarketRpt – 3 hours

The Weekly Stash Video September 30, 2022

@GreenMarketRpt – 3 hours

Florida Drops Criminal Charges Against Former Ascend Wellness Chief

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.